Literature DB >> 18728556

Pituicytoma: case report.

Stacey Quintero Wolfe1, Jocelyn Bruce, Jacques J Morcos.   

Abstract

OBJECTIVE: Pituicytoma is a rare but distinct low-grade glioma of the neurohypophysis. To date, we have found only 28 cases reported in the literature and have reviewed these in addition to our own case to delineate the clinical implications of this relatively recently defined tumor. CLINICAL
PRESENTATION: A 71-year-old woman presented with bitemporal hemianopsia and was found to have a large sellar tumor, resembling a pituitary adenoma. Transsphenoidal resection was attempted but was complicated by significant tumor vascularity. Pathology at that time was interpreted as a "granular cell tumor." The patient was then referred to our institution for management of the residual tumor. INTERVENTION: The patient underwent preoperative embolization to decrease tumor vascularity, and subtotal tumor resection was performed via a craniofacial approach. Postoperatively, the patient has enjoyed significantly improved visual fields despite residual tumor. No adjuvant treatment was given. There has been no regrowth of the residual tumor, as shown on magnetic resonance imaging, over a follow-up period of 1.5 years. The final pathological diagnosis was pituicytoma.
CONCLUSION: Pituicytomas are benign, slow-growing tumors that seem to be cured by gross total resection. The role of radiation therapy is controversial. We advocate an aggressive surgical approach with possible preoperative embolization to reduce the vascularity of the tumor.

Entities:  

Mesh:

Year:  2008        PMID: 18728556     DOI: 10.1227/01.NEU.0000335084.93093.C8

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  23 in total

Review 1.  Epithelioid pituicytoma.

Authors:  Jason A Ellis; Nadejda M Tsankova; Randy D'Amico; John C Ausiello; Peter Canoll; Marc K Rosenblum; Jeffrey N Bruce
Journal:  World Neurosurg       Date:  2011-11-07       Impact factor: 2.104

2.  Case of pituicytoma in childhood.

Authors:  Ömer Yilmaz; Aynur Turan; Hasan Yiğit; Mahmut Duymuş; Uğur Koşar
Journal:  Childs Nerv Syst       Date:  2011-11-18       Impact factor: 1.475

3.  Pituicytoma and isolated ACTH deficiency.

Authors:  John J Orrego
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

Review 4.  Pituicytoma: overview of treatment strategies and outcome.

Authors:  Ariyan Pirayesh Islamian; Rolf Buslei; Wolfgang Saeger; Rudolf Fahlbusch
Journal:  Pituitary       Date:  2012-06       Impact factor: 4.107

5.  An exceptional presentation of pituicytoma apoplexy: A case report.

Authors:  Giulia Cossu; Julien Dimitriou; Jean-Philippe Brouland; Roy Thomas Daniel; Mahmoud Messerer
Journal:  Oncol Lett       Date:  2018-05-03       Impact factor: 2.967

6.  Pituicytoma: Report of two cases.

Authors:  Zhigang Mao; Weiwei Xiao; Haijun Wang; Zhi Li; Quan Huang; Dongsheng He; Yonghong Zhu
Journal:  Oncol Lett       Date:  2010-11-23       Impact factor: 2.967

7.  Management of pituicytomas: a multicenter series of eight cases.

Authors:  Etienne Lefevre; Schahrazed Bouazza; Franck Bielle; Anne-Laure Boch
Journal:  Pituitary       Date:  2018-10       Impact factor: 4.107

Review 8.  Pituicytoma, spindle cell oncocytoma, and granular cell tumor: clarification and meta-analysis of the world literature since 1893.

Authors:  M F Covington; S S Chin; A G Osborn
Journal:  AJNR Am J Neuroradiol       Date:  2011-09-29       Impact factor: 3.825

9.  Rare infundibular tumors: clinical presentation, imaging findings, and the role of endoscopic endonasal surgery in their management.

Authors:  Maria Koutourousiou; Paul A Gardner; Julia K Kofler; Juan C Fernandez-Miranda; Carl H Snyderman; L Dade Lunsford
Journal:  J Neurol Surg B Skull Base       Date:  2012-12-31

10.  Pituicytoma with gelsolin amyloid deposition.

Authors:  Cristiane M Ida; Xiaoling Yan; Mark E Jentoft; N Sertac Kip; Bernd W Scheithauer; Jonathan M Morris; Ahmet Dogan; Joseph E Parisi; Kalman Kovacs
Journal:  Endocr Pathol       Date:  2013-09       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.